7th September 2022 | Pharma Updates

Latest pharmaceutical industry news and updates

*Refresh the page if the below document does not appear.

Akums Drugs partnered with LC Ingredients to market Cynatine in India

Akums Drugs & Pharmaceuticals Ltd. announced a collaboration with LC Ingredients to procure raw materials, manufacture, innovate, and sell finished products containing Cynatine to all Indian large pharmaceutical and nutraceutical companies.

Azithromycin, India's most commonly abused drug

Azithromycin was a common antibiotic taken in excess by Indians both during and before the Covid-19 pandemic, despite the fact that many of these medications were not approved by the national drug regulator.

Venlafaxine and Pregabalin extended release tablets approved by USFDA

Venlafaxine, used to treat depression and anxiety, and Pregabalin, used to treat pain brought on by nerve damage from diabetes or shingles (herpes zoster) infection, have both received final FDA approval for marketing.

Sun Pharma's plea against Hetero alleging trademark infringement of cancer drug Letroz rejected by HC

Sun Pharma sued Hetero Healthcare for using the generic drug Letroz, which is used as a second-line treatment for advanced breast cancer, without permission. The Delhi High Court rejected Sun Pharma’s appeal.

Bail granted to three accused of bribery at Biocon Biologics

In the Biocon Biologics-Central Drugs Standard Control Organization (CDSCO) bribery case, which the Central Bureau of Investigation is looking into, the Delhi High Court granted bail to three accused.

Following the most recent funding, Tata digital turns 1mg into unicorn

With a new funding round of more than $40 million, the start-up online pharmacy 1mg, owned by Tata, has joined the unicorn club. Tata Digital took the lead in the round. The startup’s value has increased to $1.25 billion after this round and referred to as unicorns.

As key FDA decisions in liver and lung cancers approach, AstraZeneca's Imfinzi receives an I-O first

Imfinzi is the first immunotherapy-based treatment option for this aggressive cancer type, and the FDA has approved its use in combination with chemotherapy to treat locally advanced or metastatic biliary tract cancer.

PharmaState.academy offers easy access to training & up-skilling programs created by experts from Pharma Industry.

Welcome to PharmaState Academy

Install
×
Start chat
1
Need Help?
PharmaState Academy
Hello, how can we help you?